NewsRx

Search our medical news database

Patents

U.S. patent granted for DIOP ligand family

Published in Medical Devices and Surgical Technology Week, August 31st, 2003

Chiral Quest, Inc., (CQST) announced that the U.S. Patent and Trademark Office has issued a patent (No. 6,576,772) covering composition of matter for chiral bisphosphine ligands derived from D-mannitol to The Penn State Research Foundation.

Professor Xumu Zhang, Chiral Quest's chief technology officer is the inventor on the patent. Chiral Quest, Inc., is the exclusive licensee of the patent.

DIOP ligand differs from well-known DIOP ligand in its conformational stability. Methyl groups and other substituents in DIOP are oriented in equatorial positions. This conformational difference has produced a dramatic increase of enantioselectivity for the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook